Is HAIR commercially available as a finalized product?

The program is currently presented as development-stage, and the final specification is listed as coming soon.

What is the difference between HAIR and native MSC-EV materials?

HAIR is intended to enrich selected follicle-related signals through an engineered-EV strategy, whereas native MSC-EV products retain a broader, non-engineered cargo profile.

Can partners participate in target or formulation selection?

Yes. Co-development may cover cargo strategy, producer-cell development, dose, application format, analytical methods and model design.

Does the page claim treatment of hair loss?

No. The page describes a research and co-development program and does not represent an approved or clinically proven treatment.

HAIR

A development-stage X-series program designed to enrich selected follicle-supportive and scalp-microenvironment-regulating signals for advanced hair and follicle research.

Quick Facts

Development-Stage Engineered EV Program
Program Status: Development stage
Specification: Coming soon
Target Presentation: Refrigerated
Research Focus: Follicle regeneration
Collaboration: Co-development
Development Stage
X-HAIR
Co-development
Application Model

Engineered signal enhancement for follicle-biology research.

HAIR applies Echo Biotech's engineered exosome capabilities to follicle biology. Current communication focuses on the engineering rationale, research directions and partnership opportunities while final product specifications remain under development.

Microenvironment Engineering: Designed to explore regulation of inflammatory and stress-related signals surrounding hair follicles.

Follicle-Activation Pathways: Supports research into dermal papilla signaling and transition toward the anagen phase.

Trophic-Support Strategy: Explores delivery of selected supportive signals associated with follicle and microvascular environments.

Scalable Development Path: Connects construct selection, producer-cell development, EV manufacturing, analytics and application research.

Co-development flow from construct strategy to application model

01 Target & Cargo Strategy: Confirm target pathway, cargo direction and research model.

02 Producer-Cell Development: Evaluate engineered producer-cell construction and loading strategy.

03 EV Manufacturing & Purification: Build a reproducible engineered-EV preparation workflow.

04 Loading & Identity Testing: Evaluate EV identity, loading, purity and integrity.

05 Formulation & Delivery: Explore local delivery, dose window and application format.

06 Function & Scale-Up: Connect model validation, batch consistency and further-manufacturing evaluation.

From Engineered Construct to Application-Model Evaluation

Engineered Construct Confirmation: Engineered cargo or construct strategy confirmation; Producer-cell and loading-direction evaluation; Project-level construct records and change control

EV Identity & Loading Evaluation: EV particle identity, concentration and purity; Loading-positive rate or cargo characterization; Membrane integrity and batch consistency

Functional Model Validation: Cell models selected around target pathways; Activity, stability and formulation-compatibility support; Application models expanded by collaboration scope

Co-Development Documentation: Development-stage technical package; Analytical methods and batch-result records; Connection to OEM, ODM or CDMO collaboration

Product-specific analytical focus: The development package may include engineered-cargo identity, loading-positive rate, EV purity, membrane integrity, activity, batch consistency and application-model evaluation.

Where the Product Can Fit

Inflammatory-Balance Pathway: Evaluate engineered cargo strategies intended to reduce disruptive signaling around follicles.

Dermal Papilla Activation: Study pathways associated with follicle activation and hair-cycle regulation.

Trophic and Niche Support: Explore signals related to local tissue support and follicle microenvironment quality.

Application-Format Development: Assess topical, microneedling or other local-delivery research formats as appropriate to the project.

Key Information for Technical Evaluation

Program Name: HAIR / X-HAIR

Program Type: Engineered exosome co-development program

Program Status: Development stage

Specification: Coming soon

Target Presentation: Refrigerated

Research Focus: Follicle regeneration, scalp microenvironment and local-delivery research

Collaboration: Cargo strategy, producer cell, dose, application format, analytical methods and model design

The program is development-stage. Final specification, cargo composition and formal documents are governed by the collaboration scope, TDS, quotation and batch documentation.

From Concept Validation to Engineering Collaboration

Target & Cargo Co-Development: Evaluate target pathways, cargo selection and construct strategy.

Producer Cell & Process: Support producer-cell development, EV preparation and purification optimization.

Function & Application Models: Design functional models, dose and delivery route by research scenario.

Further Manufacturing Path: Mature programs can connect to OEM, ODM or CDMO collaboration.

FAQ

Is HAIR commercially available as a finalized product?: The program is currently presented as development-stage, and the final specification is listed as coming soon.
What is the difference between HAIR and native MSC-EV materials?: HAIR is intended to enrich selected follicle-related signals through an engineered-EV strategy, whereas native MSC-EV products retain a broader, non-engineered cargo profile.
Can partners participate in target or formulation selection?: Yes. Co-development may cover cargo strategy, producer-cell development, dose, application format, analytical methods and model design.
Does the page claim treatment of hair loss?: No. The page describes a research and co-development program and does not represent an approved or clinically proven treatment.